Reviewed by the FormBlends Medical Team. Last updated: 2026-04-10
What is the Spartan stack?
The Spartan stack is a peptide combination marketed by wellness clinics for athletic performance, injury recovery, and overall physical optimization. The typical formulation includes BPC-157 (body protection compound), TB-500 (thymosin beta-4 fragment), and a growth hormone secretagogue, usually CJC-1295 paired with Ipamorelin or, in some versions, MK-677 (ibutamoren). The name "Spartan" is branding, not a clinical designation. Different clinics may use the same name for slightly different formulations. Get BPC-157 dosing right with our BPC-157 dosage guide. Regulatory status matters; check our FDA peptide ban update.
The concept behind the stack is straightforward: BPC-157 and TB-500 handle tissue repair and inflammation, while the growth hormone secretagogue supports recovery through elevated GH and IGF-1 levels. A common dosing approach splits the healing peptides to the morning and the secretagogue to the evening (to coincide with natural nighttime GH pulses). Recovery peptides are ranked in our 7 Best Peptides for Healing Injuries: Tendons, Joints & Gut guide.
What do the names Spartan, Hercules, Thor, and Wolverine mean?
These are marketing names that different clinics apply to peptide combinations. There is no standardized definition, and the same name can mean different things at different providers. That said, some loose conventions exist in the peptide community:
| Stack Name | Typical Components | Primary Goal |
|---|---|---|
| Wolverine | BPC-157 + TB-500 | Tissue healing, injury recovery |
| Spartan | BPC-157 + TB-500 + CJC-1295/Ipamorelin | Performance + recovery |
| Hercules/Thor/Zeus | BPC-157 + TB-500 + GH secretagogue + sometimes IGF-1 or additional peptides | Muscle growth + recovery + performance |
The Wolverine stack is the simplest: just BPC-157 and TB-500 for healing. The Spartan stack adds a growth hormone component to the Wolverine base, making it a performance-and-recovery protocol rather than purely a healing protocol. The more elaborate names (Hercules, Thor, Zeus) tend to include more peptides and higher doses, though the specific compositions vary widely. For muscle-building peptides, see our peptides for muscle growth guide.
What is BPC-157 and what does the evidence show?
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from a protein found in human gastric juice. It has been studied extensively in animal models, where it has shown effects on tendon, muscle, ligament, bone, and gut tissue repair.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →In rat studies, BPC-157 accelerated Achilles tendon healing, with treated animals showing increased load-to-failure and better functional recovery over 14 days compared to controls. The peptide appears to work through multiple pathways: promoting angiogenesis (new blood vessel formation), increasing growth hormone receptor expression in tendon fibroblasts, stimulating cell migration, and activating the nitric oxide system.12
The human evidence is thin. A 2025 systematic review in orthopaedic sports medicine found that only three pilot studies have examined BPC-157 in humans: one for knee pain (intra-articular injection), one for interstitial cystitis, and one for intravenous safety and pharmacokinetics. In the knee pain study, 7 of 12 patients reported pain relief lasting over six months after a single injection. No adverse effects were reported, but the sample sizes were too small to draw firm conclusions.3
The gap between the animal data and human evidence is the central issue with BPC-157. Hundreds of rodent studies show consistent healing effects. But rodent results do not always translate to humans, and large-scale human trials have not been conducted.
What is TB-500 and what does the evidence show?
TB-500 is a synthetic version of a segment of thymosin beta-4 (TB4), a 43-amino-acid protein that is naturally present in nearly all human cells. Thymosin beta-4 is involved in cell migration, blood vessel formation, and wound healing. TB-500 specifically corresponds to the active region of the protein responsible for actin binding and cell motility.
Animal studies show that thymosin beta-4 accelerates wound healing, reduces inflammation, and promotes tissue repair in skin, corneal, and cardiac tissue. It has been studied in veterinary medicine for racehorse tendon injuries, where it showed some positive results.4
Human data for TB-500 is extremely limited. Thymosin beta-4 (the parent molecule) was tested in clinical trials for chronic venous stasis ulcers and dry eye, with mixed results. TB-500 specifically has not been through human clinical trials for musculoskeletal healing or athletic recovery. Its popularity is based almost entirely on animal studies and anecdotal reports from the athletic and biohacking communities.
What role does CJC-1295/Ipamorelin play in the Spartan stack?
The growth hormone secretagogue component of the Spartan stack is intended to raise GH and IGF-1 levels, which support tissue repair, protein synthesis, and recovery. CJC-1295 (a GHRH analog) and Ipamorelin (a ghrelin receptor agonist) work through different receptors to produce additive GH release.
Growth hormone has well-documented effects on connective tissue repair: it stimulates collagen synthesis, promotes chondrocyte proliferation, and supports muscle protein synthesis. The logic of including a GH secretagogue in a recovery-focused stack is sound from a physiological standpoint.5
A secondary benefit reported by users is improved sleep quality. GH secretagogues, particularly those taken before bed, can increase slow-wave (deep) sleep duration. Since most tissue repair occurs during deep sleep, this may provide an indirect recovery benefit.
Some Spartan stack formulations substitute MK-677 (ibutamoren) for the CJC-1295/Ipamorelin combination. MK-677 is an oral ghrelin receptor agonist that provides 24-hour GH elevation. It is cheaper and does not require injections, but it also increases appetite (a significant side effect for many users) and produces more sustained GH elevation, which some clinicians consider less physiologic than pulsatile secretagogue protocols.
Who uses the Spartan stack?
The typical users fall into several categories:
- Recreational athletes and CrossFitters looking to recover faster from training and reduce chronic joint or tendon pain
- Weekend warriors in their 30s-50s dealing with overuse injuries, rotator cuff problems, tennis elbow, or Achilles tendinopathy
- Post-surgical patients hoping to accelerate recovery (though clinical evidence for this use case does not exist)
- Biohackers and longevity enthusiasts who view peptides as part of a broader optimization protocol
- Former or current athletes dealing with accumulated wear and tear
The stack has particular appeal among people who want to stay active despite nagging injuries but do not want to take NSAIDs long-term or undergo surgery. It occupies a middle ground between doing nothing and pursuing more invasive interventions. Athletes have specific needs; see our 8 Best Peptides for Athletes & Sports Recovery guide.
How does the Spartan stack compare to the Wolverine stack?
The Wolverine stack (BPC-157 + TB-500 alone) is healing-focused. It targets specific injuries or chronic pain without the growth hormone component. The Spartan stack adds CJC-1295/Ipamorelin to the Wolverine base, which broadens the intended effects to include performance optimization, body composition improvement, and systemic recovery.
| Feature | Wolverine Stack | Spartan Stack |
|---|---|---|
| Components | BPC-157 + TB-500 | BPC-157 + TB-500 + CJC-1295/Ipamorelin |
| Primary goal | Targeted injury repair | Performance + recovery + body composition |
| Injections per day | 1-2 | 2-3 |
| Cost (typical monthly) | $200-400 | $400-800 |
| Sleep benefits | Minimal | Yes (from GH secretagogue) |
| Suitable for active injury only | Yes | Yes, plus ongoing performance support |
| Human clinical trials | Minimal (BPC-157 pilot data only) | Minimal (BPC-157 pilot data + CJC PK data) |
If your primary concern is a specific injury (torn tendon, chronic tendinitis, post-surgical recovery), the Wolverine stack is the more targeted option. If you want broader recovery and performance support alongside healing, the Spartan stack adds the GH component, though at higher cost and complexity.
What are the safety considerations?
The biggest safety concern with these stacks is the lack of human clinical trial data, particularly for the combination. Individual safety profiles based on available information:
BPC-157: No adverse effects were reported in the three small human studies conducted so far. Animal toxicology studies have not revealed significant safety signals. However, some clinicians caution that BPC-157's pro-angiogenic effects could theoretically support tumor growth in people with existing cancers, though this has not been demonstrated.3
TB-500: Thymosin beta-4 has been administered in several human clinical trials (wound healing, dry eye) without serious adverse events. The same theoretical cancer concern applies to TB-500 as to BPC-157, given its role in cell migration and angiogenesis.
CJC-1295/Ipamorelin: Side effects include water retention, joint stiffness, headaches, and transient blood sugar elevation. Sustained IGF-1 elevation is a theoretical long-term concern. The CJC-1295 DAC formulation was associated with a death during early clinical development, though the circumstances were unclear and may not have been drug-related.5
People with active or suspected cancer, pregnant or nursing women, and those with diabetic retinopathy should not use these peptides. Blood work (including IGF-1, fasting glucose, and CBC) should be monitored before and during any peptide protocol.
Frequently Asked Questions
Is the Spartan stack FDA-approved?
No. None of the peptides in the Spartan stack (BPC-157, TB-500, CJC-1295, or Ipamorelin) are FDA-approved for any indication. They are used off-label or as research compounds. Clinics that prescribe them do so under physician oversight, but without the regulatory backing of FDA-approved drugs.
How long does a typical Spartan stack cycle last?
Most clinics prescribe 8-12 week cycles for the healing peptides (BPC-157, TB-500) and 12-16 week cycles for the growth hormone secretagogue. Some protocols use BPC-157 and TB-500 for a targeted healing phase and then continue CJC-1295/Ipamorelin alone for maintenance. There is no standardized guideline.
Can I use the Spartan stack while training?
Yes, most users take these peptides while continuing their training programs. The purpose of the stack is to support recovery from training and injuries, not to replace rest. However, the healing peptides may mask pain from an injury that needs rest or medical attention. Do not use peptide-driven pain relief as a reason to train through an injury that your provider has advised you to rest.
Are these peptides banned in sports?
Yes. WADA (World Anti-Doping Agency) prohibits all growth hormone secretagogues (CJC-1295, Ipamorelin, MK-677) and thymosin beta-4 (TB-500) both in-competition and out-of-competition. BPC-157 is not specifically listed on the WADA prohibited list as of early 2026, but WADA's catch-all clause for peptide hormones could apply. Competitive athletes subject to drug testing should not use any of these peptides.
Do I need to inject the Spartan stack or are there oral options?
BPC-157, TB-500, CJC-1295, and Ipamorelin are typically administered by subcutaneous injection. Oral BPC-157 is available from some compounding pharmacies and may have gut-specific benefits, but systemic bioavailability is lower than injectable forms. MK-677 is one of the few oral alternatives for the GH secretagogue component, though it has different side effect profiles.
How much does the Spartan stack cost per month?
Costs vary by clinic and source, but typical monthly expenses range from $400 to $800 for the full three-peptide stack. BPC-157 and TB-500 together usually run $200-400/month, and CJC-1295/Ipamorelin adds $200-400/month. Initial consultation fees and lab work are usually additional. Insurance does not cover these peptides.
Is there any human evidence that peptide stacks work for recovery?
Direct evidence for the combined stack is nonexistent. For individual components, BPC-157 has three small human pilot studies showing some promise for knee pain. TB-500 has no published human trials for musculoskeletal recovery. CJC-1295 and Ipamorelin have pharmacokinetic data in humans but no recovery-specific trials. The popularity of these stacks is driven primarily by animal research and anecdotal reports.
What is the difference between MK-677 and CJC-1295/Ipamorelin?
MK-677 is an oral ghrelin receptor agonist that raises GH levels continuously over 24 hours. CJC-1295/Ipamorelin is an injectable combination that produces pulsatile GH release, which more closely mirrors natural physiology. MK-677 tends to increase appetite and can cause water retention and blood sugar elevation. CJC-1295/Ipamorelin is generally considered the cleaner option but requires daily injections.
Medical References
- Chang CH, et al. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." J Appl Physiol. 2011;110(3):774-780. PMID: 21030672
- Staresinic M, et al. "Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth." J Orthop Res. 2003;21(6):976-983. PMID: 14554208
- Vasireddi N, et al. "Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review." Am J Sports Med. 2025. PMC12313605. PMC12313605
- Philp D, et al. "Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice." Wound Repair Regen. 2003;11(1):19-24. PMID: 22074882
- Teichman SL, et al. "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295." J Clin Endocrinol Metab. 2006;91(3):799-805. PMID: 16352683
Evidence standard
How this page was source-checked
FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.
PubMed evidence trail
Research sources used to frame this page
For The Spartan Stack: Performance and Recovery Peptide Protocols, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not a claim that every study applies to every patient.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.
PubMed
Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.
PubMed
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Useful for injury-recovery pages where human evidence limits need to be explicit.
PubMed
beta-Thymosins
Background source for thymosin biology and tissue-repair mechanisms.
PubMed
Thymosin beta 4 and the eye: the journey from bench to bedside
Shows how thymosin beta-4 evidence differs by route, tissue, and clinical application.
PubMed
Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies
Used only for broad regenerative-medicine context, not as proof of consumer outcomes.
PubMed
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Influence of chronic treatment with the growth hormone secretagogue Ipamorelin
Supports mechanism-level discussion while keeping evidence limits visible.
PubMed
Peptide decision path
Move from research interest to supervised review
Direct answer
The Spartan Stack: Performance and Recovery Peptide Protocols should be evaluated through research status, legal access, source quality, safety context, and clinician oversight rather than a shortcut purchase decision.
Evidence check
Useful peptide pages should separate human data, animal research, mechanistic evidence, and marketing claims.
Safety check
Peptides can vary by legal status, compounding pathway, purity testing, patient history, and interaction risk.
Next step
If the topic still fits your goal after reading, the get-started flow should collect the clinical context needed for provider review.
FormBlends Editorial Context
Reviewed May 14, 2026The Spartan stack and similar performance peptide protocols (Hercules, Thor, Zeus) combine BPC-157, TB-500, and GH secretagogues for athletic recovery. This guide covers what each component does, the evidence, safety, and how they compare to the Wolverine stack. "The Spartan Stack: Performance and Recovery Peptide Protocols" works best as a practical checklist for the next conversation. It focuses on patient education and clinical context, then narrows the issue through BPC-157, TB-500, safety and pharmacy quality. With 7 sections, the FAQ can reveal what readers usually miss. Use the page to prepare, then verify the personal medical pieces with a licensed clinician.
- Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
- Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
- Verify the pharmacy pathway, certificate of analysis, sterility testing, and clinician oversight before trusting a source.
Original tools and data
Use the FormBlends research stack
These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.
Editorial refresh
Practical 2026 note for The Spartan Stack
For this peptide therapy page, the 2026 refresh focuses on BPC-157, cash-pay pricing, safety signals, spartan, stack, performance so the article stays close to the question behind "The Spartan Stack".
The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate The Spartan Stack from nearby GLP-1, peptide, hormone, or provider-comparison searches.
Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.
Custom 2026 image for The Spartan Stack, peptide therapy, and better treatment decision-making.
Download the Peptide Quick Reference Card
A printable 2-page reference covering popular peptides, dosing ranges, stacking protocols, and storage.
Free download. We'll also send helpful GLP-1 guides to your inbox. Unsubscribe anytime.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.
Written by FormBlends Editorial Research
Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.